1. Home
  2. FULC vs PBPB Comparison

FULC vs PBPB Comparison

Compare FULC & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • PBPB
  • Stock Information
  • Founded
  • FULC 2015
  • PBPB 1977
  • Country
  • FULC United States
  • PBPB United States
  • Employees
  • FULC N/A
  • PBPB N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • PBPB Restaurants
  • Sector
  • FULC Health Care
  • PBPB Consumer Discretionary
  • Exchange
  • FULC Nasdaq
  • PBPB Nasdaq
  • Market Cap
  • FULC 375.4M
  • PBPB 305.0M
  • IPO Year
  • FULC 2019
  • PBPB 2013
  • Fundamental
  • Price
  • FULC $6.44
  • PBPB $12.35
  • Analyst Decision
  • FULC Buy
  • PBPB Strong Buy
  • Analyst Count
  • FULC 8
  • PBPB 4
  • Target Price
  • FULC $7.13
  • PBPB $16.25
  • AVG Volume (30 Days)
  • FULC 984.6K
  • PBPB 287.2K
  • Earning Date
  • FULC 07-29-2025
  • PBPB 08-06-2025
  • Dividend Yield
  • FULC N/A
  • PBPB N/A
  • EPS Growth
  • FULC N/A
  • PBPB N/A
  • EPS
  • FULC N/A
  • PBPB 0.35
  • Revenue
  • FULC N/A
  • PBPB $469,138,000.00
  • Revenue This Year
  • FULC N/A
  • PBPB $4.74
  • Revenue Next Year
  • FULC N/A
  • PBPB $4.48
  • P/E Ratio
  • FULC N/A
  • PBPB $36.23
  • Revenue Growth
  • FULC 2752.05
  • PBPB N/A
  • 52 Week Low
  • FULC $2.32
  • PBPB $6.69
  • 52 Week High
  • FULC $10.13
  • PBPB $13.67
  • Technical
  • Relative Strength Index (RSI)
  • FULC 39.24
  • PBPB 54.45
  • Support Level
  • FULC $6.47
  • PBPB $10.83
  • Resistance Level
  • FULC $7.00
  • PBPB $13.67
  • Average True Range (ATR)
  • FULC 0.57
  • PBPB 0.54
  • MACD
  • FULC -0.12
  • PBPB -0.00
  • Stochastic Oscillator
  • FULC 5.42
  • PBPB 58.10

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

Share on Social Networks: